Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 4,379.99 | 2,612.50 | 3,372.74 | 7,343.59 |
Depreciation/ Depletion | 1,521.66 | 1,244.58 | 1,126.52 | 1,055.39 |
Non- Cash Items | -25.42 | 341.89 | 217.61 | -2,718.03 |
Changesin Working Capital | -3,441.71 | -1,805.81 | 296.36 | -2,329.62 |
Cashfrom Operating Activities | 2,434.52 | 2,393.16 | 5,013.23 | 3,351.33 |
Capital Expenditures | -3,561.50 | -2,720.40 | -2,704.64 | -1,873.81 |
Other Investing Cash Flow Items Total | -694.45 | -1,257.35 | -506.92 | 2,472.50 |
Cashfrom Investing Activities | -4,255.95 | -3,977.75 | -3,211.56 | 598.69 |
Financing Cash Flow Items | -250.65 | -111.20 | -18.50 | -48.06 |
Total Cash Dividends Paid | -263.64 | -439.53 | -263.70 | -234.31 |
Issuance( Retirement)of Debt Net | 1,314.71 | 2,365.14 | -2,687.07 | -1,082.44 |
Cashfrom Financing Activities | 800.42 | 1,814.41 | -2,969.27 | -1,364.81 |
Foreign Exchange Effects | 14.17 | -0.06 | 0.20 | -2.12 |
Net Changein Cash | -1,006.84 | 229.76 | -1,167.40 | 2,583.09 |
Cash Interest Paid | 250.65 | 111.20 | 18.50 | 48.06 |
Cash Taxes Paid | 1,766.64 | 717.24 | 1,258.19 | 1,285.25 |
Issuance( Retirement)of Stock Net | - | - | - | 0.00 |
Aurobindo Pharma Dividend Aurobindo Pharma Bonus Aurobindo Pharma News Aurobindo Pharma AGM Aurobindo Pharma Rights Aurobindo Pharma Splits Aurobindo Pharma Board Meetings Aurobindo Pharma Key Metrics Aurobindo Pharma Shareholdings Aurobindo Pharma Profit Loss Aurobindo Pharma Balance Sheet Aurobindo Pharma Q1 Results Aurobindo Pharma Q2 Results Aurobindo Pharma Q3 Results Aurobindo Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks